Martha Viviane Feller, Moreira José da Silva, Martha Aline Silveira, Velho Flávio José, Eick Renato George, Goncalves Sandro Cadaval
Department of Otorhinolaryngology, Sao Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Int J Pediatr Otorhinolaryngol. 2013 Feb;77(2):237-40. doi: 10.1016/j.ijporl.2012.11.006. Epub 2012 Dec 11.
Adenotonsillar hypertrophy is a common condition in pediatric patients with upper respiratory airways complaints, and pulmonary arterial hypertension (PAH) may be one complication of that condition.
To study the occurrence of PAH (mean pulmonary artery pressure higher than or equal to 25 mmHg) in a group of children with adenotonsillar hypertrophy and upper respiratory complaints (snoring or oral breathing), and to verify the pulmonary arterial pressure (PAP) changes after adenotonsillectomy.
Case-control prospective study.
Study conducted at São Lucas Hospital, approaching both public and private sector.
Thirty-three pediatric patients with adenotonsillar hypertrophy and evidence of obstructive upper airways complaints were treated with adenotonsillectomy. All 33 patients underwent echocardiogram before and after the surgery with determination of the pulmonary arterial pressure (PAP), through either the tricuspid regurgitation or artery linear flow acceleration time estimation. Similar determinations were performed in 10 normal non operated controls.
Pulmonary hypertension was verified 12 (36%) of the 33 patients with adenotonsillar hypertrophy. Adenoidectomy or adenotonsillectomy was associated to a significant 27% decrease in mean PAP (27 ± 2.8 to 20 ± 5.1 mmHg, p<0.001) and to a non significant 26% decrease in systolic PAP (35 ± 6.2 mmHg to 25 ± 0.5 mmHg, p=0.243). The PAP values in children with no pulmonary hypertension were not changed after the surgery.
In children with pulmonary hypertension associated to adenotonsillar hypertrophy, the adenotonsillectomy decreased PAP to normal values in all patients.
腺样体扁桃体肥大是患有上呼吸道疾病的儿科患者的常见病症,肺动脉高压(PAH)可能是该病症的一种并发症。
研究一组患有腺样体扁桃体肥大及上呼吸道疾病(打鼾或口呼吸)的儿童中PAH(平均肺动脉压高于或等于25mmHg)的发生率,并验证腺样体扁桃体切除术后的肺动脉压(PAP)变化。
病例对照前瞻性研究。
在圣卢卡斯医院进行的研究,涉及公共和私营部门。
33例患有腺样体扁桃体肥大并有阻塞性上呼吸道疾病证据的儿科患者接受了腺样体扁桃体切除术。所有33例患者在手术前后均接受了超声心动图检查,通过三尖瓣反流或动脉线性血流加速时间估计来测定肺动脉压(PAP)。对10例未手术的正常对照进行了类似测定。
33例腺样体扁桃体肥大患者中有12例(36%)被证实患有肺动脉高压。腺样体切除术或腺样体扁桃体切除术使平均PAP显著降低27%(从27±2.8mmHg降至20±5.1mmHg,p<0.001),收缩期PAP降低26%但无统计学意义(从35±6.2mmHg降至25±0.5mmHg,p=0.243)。无肺动脉高压的儿童术后PAP值未发生变化。
在患有与腺样体扁桃体肥大相关的肺动脉高压的儿童中,腺样体扁桃体切除术使所有患者的PAP降至正常水平。